Tackling obesity during the COVID-19 pandemic

Diabetes Metab Res Rev. 2021 Mar;37(3):e3393. doi: 10.1002/dmrr.3393. Epub 2020 Aug 29.

Amit Akirov^{1

2}, Avivit Cahn³, Stefano Del Prato⁴, Philip Home⁵, Luc Van Gaal⁶, Juliana Chan^{7

8

9}, Guang Ning¹⁰, Itamar Raz³

¹ Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel.
² Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Diabetes Unit, Department of Endocrinology and Metabolism, Faculty of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
⁴ Department of Clinical & Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy.
⁵ Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
⁶ Department of Endocrinology & Metabolism, Antwerp University Hospital, Edegem-Antwerp, Belgium.
⁷ Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
⁸ Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
⁹ Li Ka Shing Institute of Health Science, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
¹⁰ Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.

No abstract available

Keywords: COVID-19; diabetes; obesity; pre-diabetes.

MeSH terms